Novartis licenses rights to RNA-targeting cardio drug from Ionis

Singapore News News

Novartis licenses rights to RNA-targeting cardio drug from Ionis
Singapore Latest News,Singapore Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Swiss drugmaker Novartis said on Monday it is exercising its option to license rights to an investigational, RNA-targeting cardiovascular drug ...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Personality on the morning commute: Australia's emoji licence platesPersonality on the morning commute: Australia's emoji licence platesBRISBANE: Motorists in northeastern Australia can soon have their personality permanently stamped on their vehicles with the option of an emoji ...
Read more »

New microbreweries can pay pro-rated licence fee from May under new frameworkNew microbreweries can pay pro-rated licence fee from May under new frameworkSINGAPORE - Something is brewing for aspiring start-ups in the microbrewery industry.. Read more at straitstimes.com.
Read more »



Render Time: 2025-04-05 11:58:04